Intravenous immunoglobulin therapy (IVIg) has been used to treat patients with a wide range of neuromuscular diseases, but may carry a risk of causing or exacerbating deep venous thrombosis (DVT) in the lower extremities. To investigate whether IVIg induces DVT, we retrospectively reviewed patients with neuromuscular disease who had received IVIg. Medical records of patients with neurological disorders administered IVIg between January and October 2014 were reviewed. Of 66 patients who received IVIg, 14 underwent ultrasonography. DVT was detected in 3 patients (4.5%): after IVIg in 2; and before IVIg in 1. Activities of daily living were impaired in all 3 patients due to neurological symptoms. All received immediate anticoagulation and achieved favorable outcomes without any thromboembolic events, demonstrating regression or organization of DVT on repeat ultrasonography. When conducting IVIg in patients with neuromuscular diseases, clinicians should monitor changes in clinical symptoms or markers of fibrinolytic activity such as D-dimer to detect DVT early.

